A detailed history of D. E. Shaw & Co., Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 208,541 shares of MEDP stock, worth $71.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
208,541
Holding current value
$71.5 Million
% of portfolio
0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$320.58 - $457.29 $29.3 Million - $41.8 Million
-91,324 Reduced 30.46%
208,541 $69.5 Million
Q2 2024

Aug 14, 2024

SELL
$372.0 - $424.34 $26.9 Million - $30.6 Million
-72,214 Reduced 19.41%
299,865 $123 Million
Q1 2024

May 15, 2024

BUY
$284.87 - $413.31 $40 Million - $58.1 Million
140,519 Added 60.68%
372,079 $150 Million
Q4 2023

Feb 14, 2024

BUY
$227.52 - $312.68 $19.8 Million - $27.3 Million
87,240 Added 60.45%
231,560 $71 Million
Q3 2023

Nov 14, 2023

SELL
$233.98 - $281.67 $26.8 Million - $32.3 Million
-114,693 Reduced 44.28%
144,320 $34.9 Million
Q2 2023

Aug 14, 2023

BUY
$187.26 - $240.17 $20.3 Million - $26.1 Million
108,623 Added 72.23%
259,013 $62.2 Million
Q1 2023

May 15, 2023

BUY
$174.31 - $239.52 $1.37 Million - $1.88 Million
7,861 Added 5.52%
150,390 $28.3 Million
Q4 2022

Feb 14, 2023

BUY
$153.06 - $226.57 $15 Million - $22.2 Million
98,200 Added 221.53%
142,529 $30.3 Million
Q3 2022

Nov 14, 2022

SELL
$145.13 - $182.49 $248,752 - $312,787
-1,714 Reduced 3.72%
44,329 $6.97 Million
Q2 2022

Aug 15, 2022

BUY
$130.2 - $168.03 $2.9 Million - $3.74 Million
22,272 Added 93.69%
46,043 $6.89 Million
Q1 2022

May 16, 2022

BUY
$138.87 - $214.31 $1.71 Million - $2.65 Million
12,346 Added 108.06%
23,771 $3.89 Million
Q4 2021

Feb 14, 2022

BUY
$182.74 - $227.9 $675,772 - $842,774
3,698 Added 47.86%
11,425 $2.49 Million
Q3 2021

Nov 15, 2021

SELL
$170.18 - $198.21 $1.61 Million - $1.88 Million
-9,462 Reduced 55.05%
7,727 $1.46 Million
Q2 2021

Aug 16, 2021

SELL
$158.62 - $194.3 $2.71 Million - $3.32 Million
-17,112 Reduced 49.89%
17,189 $3.04 Million
Q1 2021

May 17, 2021

SELL
$132.02 - $168.26 $6.63 Million - $8.46 Million
-50,253 Reduced 59.43%
34,301 $5.63 Million
Q4 2020

Feb 16, 2021

SELL
$109.38 - $149.19 $20.1 Million - $27.5 Million
-184,076 Reduced 68.52%
84,554 $11.8 Million
Q3 2020

Nov 16, 2020

BUY
$92.95 - $130.61 $3.84 Million - $5.4 Million
41,310 Added 18.17%
268,630 $30 Million
Q2 2020

Aug 14, 2020

SELL
$68.08 - $95.68 $3.43 Million - $4.83 Million
-50,452 Reduced 18.16%
227,320 $21.1 Million
Q1 2020

May 15, 2020

BUY
$61.71 - $101.95 $5.62 Million - $9.29 Million
91,079 Added 48.79%
277,772 $20.4 Million
Q4 2019

Feb 14, 2020

SELL
$70.08 - $84.64 $7.35 Million - $8.88 Million
-104,933 Reduced 35.98%
186,693 $15.7 Million
Q3 2019

Nov 14, 2019

BUY
$62.38 - $85.89 $7.53 Million - $10.4 Million
120,688 Added 70.6%
291,626 $24.5 Million
Q2 2019

Aug 14, 2019

SELL
$53.64 - $65.42 $2.32 Million - $2.83 Million
-43,234 Reduced 20.19%
170,938 $11.2 Million
Q1 2019

May 15, 2019

SELL
$49.38 - $70.58 $4.21 Million - $6.02 Million
-85,293 Reduced 28.48%
214,172 $12.6 Million
Q4 2018

Feb 14, 2019

SELL
$46.97 - $63.98 $11.3 Million - $15.4 Million
-241,334 Reduced 44.63%
299,465 $15.9 Million
Q3 2018

Nov 14, 2018

BUY
$43.25 - $63.74 $18.9 Million - $27.8 Million
436,834 Added 420.17%
540,799 $32.4 Million
Q2 2018

Aug 14, 2018

SELL
$34.03 - $45.46 $245,322 - $327,721
-7,209 Reduced 6.48%
103,965 $4.47 Million
Q1 2018

May 15, 2018

SELL
$32.03 - $39.05 $1.79 Million - $2.18 Million
-55,859 Reduced 33.44%
111,174 $3.88 Million
Q4 2017

Feb 14, 2018

BUY
$32.46 - $38.31 $3.29 Million - $3.88 Million
101,341 Added 154.27%
167,033 $6.06 Million
Q3 2017

Nov 14, 2017

BUY
$27.43 - $33.11 $1.8 Million - $2.18 Million
65,692
65,692 $2.1 Million

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.7B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.